America’s progress in cancer research seems to be moving at a slow pace, contradicting President Joe Biden’s claim of “ending cancer as we know it.” During a speech that lacked clarity and coherence, Biden expressed his desire to cure cancer, but his statement was marred by a gaffe. Instead of saying “We can end cancer as we know it,” he mistakenly said, “We ended cancer as we know it.” This blunder comes at a time when the data indicates a slow decline in cancer mortality rates.
Although there has been a 33% reduction in death rates since 1991, saving 3.8 million lives, the recent annual decline of just 1.5% raises concerns about the pace of progress. The graphs above illustrate the diagnosis and fatality rates for various types of cancer, showing a downward trend in fatality rates overall, while case rates remain steady. Furthermore, projections for 2023 indicate an increase in cancer diagnoses and deaths.
President Biden previously initiated the Cancer Moonshot operation in 2016, and he announced its revival in 2022. His personal connection to cancer, having lost his son to the disease, fuels his determination to reduce the cancer death rate by half within the next 25 years. However, researchers from the National Institutes of Health argue that achieving this goal at the current rate of decline (2.3%) would be “impossible.”
Alarming studies reveal a significant rise in cancer cases among adults under 50 years old, including breast, colorectal, endometrial, and kidney cancers. The causes of these increases may be attributed to improved screening methods, but there is also a possibility of increased exposure to risk factors during early life or young adulthood.
The National Cancer Institute’s annual report for 2022 demonstrates progress in reducing mortality rates for certain cancers in both men and women. Notable declines were observed in lung, skin, kidney, and stomach cancers, but pancreatic, liver, bone, and brain cancers showed an increase in mortality rates.
Looking ahead to 2023, projections suggest that approximately 1.95 million Americans will be diagnosed with cancer, with an estimated 609,820 deaths. Breast cancer remains the most common diagnosis for women, while prostate cancer holds that position for men. Lung and bronchus cancer are expected to cause the most deaths.
The COVID-19 pandemic has inevitably impacted cancer rates and deaths. The disruption of health services, resulting in missed or postponed cancer screenings and delayed treatments, will likely contribute to an increase in cancer cases diagnosed at later stages. This influx of cases puts additional strain on an already burdened healthcare system in the US. The true extent of these consequences will become evident in the coming years as statistics are analyzed.
It is clear that despite efforts and initiatives, the battle against cancer is far from over. Additional research, resources, and a focused approach are necessary to improve outcomes and ultimately achieve the goal of conquering cancer.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
